Literature DB >> 10197744

Ocular surface disease in atopic dermatitis.

M Dogru1, N Nakagawa, K Tetsumoto, C Katakami, M Yamamoto.   

Abstract

PURPOSE: To describe the ocular surface disorders of 362 patients with severe active atopic dermatitis (AD) treated in the Ophthalmology Department of Kobe University Hospital and Kobe Rosai Hospital Eye Clinics during the period 1994-1996.
METHODS: Routine ophthalmic examinations as well as tear film break-up time (BUT) and Schirmer tests were carried out.
RESULTS: Lid eczema (65.7%), atopic keratoconjunctivitis, and superficial punctate keratopathy (67.5%) were the dominant ocular diseases in these patients. Tear function tests showed a BUT value of less than 10 seconds in 62.4% of the eyes and a Schirmer test value of less than 5 mm in 56.2% of the eyes.
CONCLUSIONS: A careful examination of the ocular surface is essential in treating AD patients. We also suggest that the ocular surface disorders in AD may be due to allergic reactions and disorders in tear film quantity or quality.

Entities:  

Mesh:

Year:  1999        PMID: 10197744     DOI: 10.1016/s0021-5155(98)00061-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  10 in total

1.  Ocular Surface Squamous Neoplasia Associated with Atopic Keratoconjunctivitis.

Authors:  Ankit Shah; Edgar M Espana; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2016-09-10

2.  Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.

Authors:  Roselie E Achten; Chantal Van Luijk; Lisa Van der Rijst; Daphne Bakker; Lotte Spekhorst; Nicolaas Zuithoff; Marie Schuttelaar; Geertruida Romeijn; Angelique Voorberg; Marijke Kamsteeg; Inge Haeck; Marlies De Graaf; Judith Thijs; Joke De Boer; Marjolein De Bruin-Weller
Journal:  Acta Derm Venereol       Date:  2022-03-11       Impact factor: 3.875

3.  Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

Authors:  Erminia Ridolo; P Kihlgren; I Pellicelli; M C Nizi; F Pucciarini; C Incorvaia
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

Review 4.  [Diagnosis and treatment of eyelid eczema. An interdisciplinary challenge].

Authors:  A Wollenberg; K Kerschenlohr; T Pavicic; E M Messmer
Journal:  Hautarzt       Date:  2004-07       Impact factor: 0.751

Review 5.  [Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

Authors:  P Maier; T Lapp; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

6.  Alterations in Mucin-Associated Gene Expression on the Ocular Surface in Active and Stable Stages of Atopic and Vernal Keratoconjunctivitis.

Authors:  Mariko Horinaka; Jun Shoji; Akiko Tomioka; Yukiko Tonozuka; Noriko Inada; Satoru Yamagami
Journal:  J Ophthalmol       Date:  2021-05-31       Impact factor: 1.909

7.  Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis.

Authors:  Tais Hitomi Wakamatsu; Mari Tanaka; Yoshiyuki Satake; Murat Dogru; Kazumi Fukagawa; Ayako Igarashi; Hiroshi Fujishima
Journal:  Mol Vis       Date:  2011-04-13       Impact factor: 2.367

8.  Investigation of the clinical features in filamentary keratitis in Hangzhou, east of China.

Authors:  Siming Chen; Yimeng Ruan; Xiuming Jin
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Cataract, Glaucoma, and Dry Eye Disease in Adults with Atopic Dermatitis: A Nationwide Cross-Sectional Study from the Republic of Korea.

Authors:  Sul Hee Lee; Sang-Hoon Lee; Si Hyung Lee; Young Lip Park
Journal:  Ann Dermatol       Date:  2019-01-02       Impact factor: 1.444

Review 10.  Potential Biomarkers for Allergic Conjunctival Diseases.

Authors:  Neeta Roy; Shir Levanon; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.